CTRI/2021/04/032697尚未招募未知
Incidence and outcome of renal dysfunction in patients with liver cirrhosis.
Dr Philip Abraham0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •1.Consenting patients with cirrhosis of liver attending the outpatient / inpatient services of Division of Gastroenterology.
- •Cirrhosis of liver is defined as the histological development of regenerative nodules surrounded by fibrous bands in response to chronic liver injury, that leads to portal hypertension and end stage liver disease
- •In clinical practice, the diagnosis is based on a combination of clinical, biochemical and radiological findings with or without evidence of varices on endoscopic evidence.
- •2. Age above 18 years
排除标准
- •Patients with tuberculosis, cancer or other severe co-morbidities that will affect the outcome independently will be excluded
研究者
相似试验
已完成
不适用
Influence of renal dysfunction on the outcomes of hepatectomy for hepatocellular carcinomaHepatocellular carcinomaJPRN-UMIN000041749Hiroshima University238
尚未招募
不适用
A study of kidney Problems with covid 19 in admitted patients at a teritiary care hospital.CTRI/2020/12/029581nil
招募中
不适用
The analysis of renal complication associated with Rheumatoid ArthritisRheumatoid ArhtritisJPRN-UMIN000032529Toranomon hospital120
Unknown
不适用
A Cross-sectional Study for Renal Function of Patients With Chronic Hepatitis B in ChinaHepatitis B, ChronicNCT04538651Sun Yat-sen University11,453
进行中（未招募）
1 期
Evaluation of the impact of renal function on the pharmacokinetics of hydroxyurea (Siklos®) in patients with sickle cell disease with normal renal function, with hyperfiltration, or with renal failure. DARH studySiklos is indicated for the prevention of recurrent painful vaso-occlusive crises including acute chest syndrome in adults, adolescents and children older than 2 years suffering from symptomatic sickle cell syndrome.MedDRA version: 17.1Level: LLTClassification code 10040643Term: Sickle cell crisisSystem Organ Class: 100000004851EUCTR2014-005033-31-FRAddmedica S.A.S